Immunoreactivity to pyruvate dehydrogenase complex-E2 in well-defined patients with autoimmune hepatitis: Western blot analysis.

[1]  M. Beaugrand,et al.  Antimitochondrial antibodies in patients with chronic hepatitis C. , 2008, Liver.

[2]  A. Tanaka,et al.  Detection of antimitochondrial autoantibodies in immunofluorescent AMA‐negative patients with primary biliary cirrhosis using recombinant autoantigens , 2001, Hepatology.

[3]  M. Manns,et al.  Autoimmune hepatitis: clinical challenges. , 2001, Gastroenterology.

[4]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[5]  G. Gerken,et al.  Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals , 1999, Hepatology.

[6]  J. Neuberger,et al.  PBC and AMA—what is the connection? , 1999, Hepatology.

[7]  K. Kikuchi,et al.  Combination assays for IgG class and IgM class anti-pyruvate dehydrogenase complex(PDC)-E2 by ELISA using recombinant autoantigen to diagnose primary biliary cirrhosis , 1998 .

[8]  S. Sherlock.  Autoimmune Cholangitis: A Unique Entity? , 1998 .

[9]  S. Sherlock.  Ludwig Symposium on biliary disorders. Autoimmune cholangitis: a unique entity? , 1998, Mayo Clinic proceedings.

[10]  D. V. van Thiel,et al.  A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. , 1997, Hepato-gastroenterology.

[11]  R. Coppel,et al.  Antimitochondrial antibodies in primary biliary cirrhosis. , 1997, Seminars in liver disease.

[12]  F. Colina,et al.  Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? , 1996, Journal of clinical gastroenterology.

[13]  Ross,et al.  Epitope mapping and reactivity of autoantibodies to the E2 component of 2‐oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2‐oxoglutarate dehydrogenase complex , 1996, Hepatology.

[14]  H. Oide,et al.  Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. , 1995, Internal medicine.

[15]  H. Bonkovsky,et al.  High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C , 1995, Hepatology.

[16]  P. Scheuer,et al.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. , 1994, Gut.

[17]  C. Riely,et al.  Primary Autoimmune Cholangitis: An Alternative to Antimitochondrial Antibody‐Negative Primary Biliary Cirrhosis , 1994, The American journal of surgical pathology.

[18]  M. Manns,et al.  Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. , 1993, Gastroenterology.

[19]  A. Dhillon,et al.  Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis , 1993, Hepatology.

[20]  A. Craxì,et al.  Immunoblotting as a confirmatory test for antimitochondrial antibodies in primary biliary cirrhosis. , 1993, Gut.

[21]  B. Neel,et al.  Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. , 1993, Analytical biochemistry.

[22]  M. Manns,et al.  Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. , 1992, Gastroenterology.

[23]  M. Kaplan,et al.  Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases , 1992, Journal of Clinical Immunology.

[24]  R. Coppel,et al.  Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Chuang,et al.  Conservation of primary structure in the lipoyl-bearing and dihydrolipoyl dehydrogenase binding domains of mammalian branched-chain alpha-keto acid dehydrogenase complex: molecular cloning of human and bovine transacylase (E2) cDNAs. , 1988, Biochemistry.

[26]  I. Mackay,et al.  Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. , 1987, Journal of immunology.

[27]  E. Dickson,et al.  Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis , 1986, Digestive Diseases and Sciences.

[28]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Elveback,et al.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. , 1972, Gastroenterology.

[30]  J. G. Walker,et al.  SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. , 1965, Lancet.

[31]  I. Mackay.  Primary biliary cirrhosis showing a high titer of autoantibody; report of a case. , 1958, The New England journal of medicine.

[32]  W. C. Schneider,et al.  INTRACELLULAR DISTRIBUTION OF ENZYMES V. FURTHER STUDIES ON THE DISTRIBUTION OF CYTOCHROME c IN RAT LIVER HOMOGENATES , 1950 .

[33]  K. Kikuchi,et al.  Serial changes of serum anti-M2 proteins in patients with primary biliary cirrhosis: a follow-up study by immunoblotting , 1999 .

[34]  H. Slor,et al.  Detection of antimitochondrial antibodies: characterization by enzyme immunoassay and immunoblotting. , 1989, Autoimmunity.